5536-17-4 vidarabine
상품명칭 |
vidarabine |
영문 이름 |
vidarabine; 6-Amino-9-beta-D-arabinofuranosylpurine; 9-(beta-D-Arabinofuranosyl)-9H-purin-6-amine; 9-(beta-D-glycero-Pentofuranosyl)-9H-purin-6-amine; 9-beta-D-Arabinofuranosyl-9H-purin-6-amine; 9-beta-D-Arabinofuranosyladenine; 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-; 9H-purin-6-amine, 9-beta-D-glycero-pentofuranosyl-; Adenine, 9-beta-D-arabinofuranosyl-; 9-β-D-arabinopyranosyl-9H-purin-6-amine; 9-β-D-Arabinofuranosyl-adenine |
분자식 |
C10H13N5O4 |
분자량 |
267.2413 |
InChI |
InChI=1/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(16)1-19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1 |
cas번호 |
5536-17-4 |
EC번호 |
226-893-9 |
분자 구조 |
|
밀도 |
2.08g/cm3 |
비등점 |
639.5°C at 760 mmHg |
굴절 지수 |
1.907 |
인화점 |
340.6°C |
증기압 |
3.14E-17mmHg at 25°C |
위험성 표시 |
Xn:Harmful;
|
리스크 규칙 |
R63:;
|
보안 규칙 |
S36/37:;
|
|